Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

ARMH, ARUN, NUAN, PWRM - Market News From DrStockPick.com!

drstock-2-3

signup3m


power3

Power3 Medical Products, Inc. (OTC.BB:PWRM) is a breakthrough proteomics company specializing in the identification of disease footprints in the areas of chemotherapeutic drug resistance and the early detection of breast cancer and neurological diseases.

Power3 leverages its knowledge of proteomics to detect diseases earlier than currently thought possible. The focus of Power3's efforts is on developing very sensitive patient tests that will enable doctors to diagnose and treat a disease before it becomes life-threatening or debilitating.

BC-SeraPro™ is a proteomic test for the diagnosis of breast cancer. This test is designed to measure the quantitative expression level of 22 protein biomarkers in the serum that differentiate between breast cancer patients and control subjects. The level of the biomarkers from the patient’s serum sample is compared to the Power3 Medical Products’ patient database. Statistical analysis by linear discriminant function will analyze the biomarker levels of the patient sample and assign a probability score for the diagnosis of the patient sample. Probability score is ranged from 0.0 to 1.0. Results of the BC-SeraPro™ test should not be considered a stand alone diagnosis nor a guarantee.

The NuroPro Blood Test is Power3’s diagnostic tool for the early detection of Neurodegenerative diseases. The analysis is designed as a tool for physicians to diagnose various degenerative diseases of the brain and nervous system. The test involves monitoring the concentration of 59 proteins in blood serum to accurately detect and distinguish between Alzheimer’s disease, ALS (Lou Gehrig’s disease), and Parkinson’s disease . Early detection of these diseases will allow physicians to intervene at an early stage to delay disease progression, potentially allowing patients to outlive their debilitating symptoms.

****************************************

Nuance Communications, Inc (Nasdaq:NUAN) announced the availability of Dragon Medical Mobile Recorder on the iTunes App Store, expanding its healthcare suite of speech solutions for smartphones and building upon the recent success of Dragon Medical Mobile Search.

Nuance Communications, Inc. offers speech, imaging, and keypad solutions for businesses, organizations, and consumers worldwide. The company provides dictation and transcription solutions and services that automate the input and management of medical information to hospitals, clinics, group practices, and physicians; and speech recognition solutions to dictate, edit, and sign reports without manual transcription for radiology, cardiology, pathology, and related specialties.

****************************************

Aruba Networks, Inc. (Nasdaq:ARUN) announced recently that the Aruba Operating System Release 5.0 (ArubaOS 5.0) has won the UK’s Computing Security Magazine’s Wireless Security Product of the Year Award. Awards were conferred upon one vendor or service provider in each of 23 unique categories based on feedback from readers. The wireless security category included a wide range of Wi-Fi related products, and the ArubaOS 5.0 operating system was voted by users to be the overall winner.

Aruba Networks, Inc. provides an enterprise mobility solution that enables secure access to data, voice, and video applications across wireless and wireline enterprise networks in the United States and internationally.

****************************************

ARM Holdings plc (Nasdaq:ARMH) announced on December 13, 2010, the availability of Version 2.0 of the ARM Cortex™ Microcontroller Software Interface Standard (CMSIS). The enhanced version of the vendor-independent hardware abstraction layer contains extensions for the Cortex-M4 processor and includes the CMSIS-DSP (Digital Signal Processing) library of highly optimized signal processing algorithms.

ARM Holdings plc designs microprocessors, physical intellectual property (NYSE:IP), and related technology and software, as well as sells development tools to enhance the performance of high-volume embedded applications.

****************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

drstbc

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (OTC:PWRM).